1.Clinical application of metagenomic next generation sequencing in detection of pathogens from patients with pulmonary infections
Yu LIU ; Xiaoqin SUN ; Ting LIU ; Xiwen SHEN ; Mei ZHANG ; Yali XU ; Weidong HU
Chinese Journal of Nosocomiology 2025;35(13):1942-1947
OBJECTIVE To explore the clinical value of metagenomic next generation sequencing(mNGS)in detec-tion of pathogens from the patients with pulmonary infection.METHODS The clinical data were collected from 103 patients with pulmonary infection who were treated in respiratory and critical care medicine department of Gansu Province People's Hospital from Jun.2021 to Jun.2023.The pathogens were detected from all of the patients with the use of mNGS for bronchoalveolar lavage fluid(BALF)and traditional cultures(including sputum culture and BALF culture).The positive rates,consistency,distribution,efficacy and curative effects were observed and sys-tematically compared between the two detection methods.RESULTS Totally 122 strains of bacteria,47 strains of fungi,94 strains of viruses,3 strains of Mycoplasma and 2 strains of Chlamydia were detected from the 103 pa-tients by mNGS,as compared with only 45 strains of bacteria and 20 strains of fungi that were detected by the tra-ditional culture method.The positive rate of detection of pathogens was 89.32%by mNGS,higher than 38.83%of the traditional culture method(P<0.001).There was certain difference in the distribution of pathogens be-tween the two detection method,the two detection method showed the poor consistency of detection efficacy,and the effect of targeted drug therapy based on the mNGS-detected pathogens was higher than that of the mNGS-negative empirical therapy(P<0.001).In addition,some of drug resistance genes could be detected by mNGS.CONCLUSIONS The mNGS shows remarkable higher efficacy in detection of the pathogens causing pul-monary infections than the traditional culture method and can detect various types of pathogens.The effect of the targeted drug therapy based on the pathogens detected by mNGS is remarkable.It plays an imorptant role in guid-ing the clinical diagnosis and treatment of the patients with pulmonary infections.
2.Clinical application of metagenomic next generation sequencing in detection of pathogens from patients with pulmonary infections
Yu LIU ; Xiaoqin SUN ; Ting LIU ; Xiwen SHEN ; Mei ZHANG ; Yali XU ; Weidong HU
Chinese Journal of Nosocomiology 2025;35(13):1942-1947
OBJECTIVE To explore the clinical value of metagenomic next generation sequencing(mNGS)in detec-tion of pathogens from the patients with pulmonary infection.METHODS The clinical data were collected from 103 patients with pulmonary infection who were treated in respiratory and critical care medicine department of Gansu Province People's Hospital from Jun.2021 to Jun.2023.The pathogens were detected from all of the patients with the use of mNGS for bronchoalveolar lavage fluid(BALF)and traditional cultures(including sputum culture and BALF culture).The positive rates,consistency,distribution,efficacy and curative effects were observed and sys-tematically compared between the two detection methods.RESULTS Totally 122 strains of bacteria,47 strains of fungi,94 strains of viruses,3 strains of Mycoplasma and 2 strains of Chlamydia were detected from the 103 pa-tients by mNGS,as compared with only 45 strains of bacteria and 20 strains of fungi that were detected by the tra-ditional culture method.The positive rate of detection of pathogens was 89.32%by mNGS,higher than 38.83%of the traditional culture method(P<0.001).There was certain difference in the distribution of pathogens be-tween the two detection method,the two detection method showed the poor consistency of detection efficacy,and the effect of targeted drug therapy based on the mNGS-detected pathogens was higher than that of the mNGS-negative empirical therapy(P<0.001).In addition,some of drug resistance genes could be detected by mNGS.CONCLUSIONS The mNGS shows remarkable higher efficacy in detection of the pathogens causing pul-monary infections than the traditional culture method and can detect various types of pathogens.The effect of the targeted drug therapy based on the pathogens detected by mNGS is remarkable.It plays an imorptant role in guid-ing the clinical diagnosis and treatment of the patients with pulmonary infections.
3.Progress in animal model research on obstructive sleep apnea
Yubin SHEN ; Xiwen OU ; Song LIU
Journal of Shanghai Jiaotong University(Medical Science) 2024;44(4):501-508
Obstructive sleep apnea(OSA)is a common sleep disorder,and its pathophysiological mechanism complex and not fully understood.This article elaborately explores three categories of OSA animal models:natural,direct and indirect,emphasizing their advantages and disadvantages in simulating OSA pathophysiological processes.Natural OSA models primarily focus on spontaneous upper airway obstructions.Direct OSA models induce OSA through direct obstruction of the airway,while indirect OSA models mainly investigate the impacts of chronic intermittent hypoxia(IH)and sleep deprivation(SD)on the organism.Although these models have played a pivotal role in studying the pathophysiological mechanisms of OSA and developing new therapeutic methods,they also present certain limitations and challenges.Future research directions include the development of non-invasive monitoring technologies,establishing OSA-combined models,and the application of gene-editing technologies,aiming to more comprehensively and accurately simulate the complexity and diversity of human OSA,providing more insights into its mechanisms and developing new therapeutic methods.
4.Efficacy and safety of antibody-drug conjugates in the treatment of breast cancer:a meta-analysis
Yinxue XU ; Lei ZHANG ; Xiwen QIAO ; Xiaolan SHEN ; Qian SHEN ; Xuehui ZHANG
China Pharmacy 2023;34(20):2540-2544
OBJECTIVE To evaluate the efficacy and safety of antibody-drug conjugates (ADC) in the treatment of breast cancer, so as to provide an evidence-based reference for clinical medication. METHODS Retrieved from CNKI, Wanfang database, VIP, PubMed, the Cochrane Library, Embase, and Web of Science, randomized controlled trials (RCTs) about trastuzumab emtansine, trastuzumab deruxtecan and sacituzumab govitecan (trial group) versus chemotherapy or other anti-tumor drugs (control group), were collected during the inception to April 2023. After screening the literature, extracting data, and evaluating the quality of the literature, a meta-analysis was conducted by using RevMan 5.4.1 software. RESULTS A total of 8 RCTs were included, with a total of 5 577 patients. The results of the meta-analysis showed that the progression-free survival (PFS) [HR=0.76, 95%CI (0.69, 0.83), P<0.000 01], overall survival (OS) [HR=0.87, 95%CI (0.81, 0.93), P<0.000 1], and clinical benefit rate (CBR) [OR=2.70, 95%CI (1.15, 6.33), P=0.02] of the trial group were significantly higher than control group. There was no statistically significant difference in objective response rate (ORR) between the two groups [OR=2.34, 95%CI (0.59, 9.33), P=0.23]. The results of subgroup analysis showed that the PFS of HER2-positive patients and HER2-negative patients, and the OS of HER2-positive patients in the trial group were significantly higher than control group (P<0.05). The incidence of anemia and increase of aspartic acid transaminase (AST) in the trial group was significantly higher than control group (P<0.05). The results of sensitivity analysis showed that the results obtained with PFS, OS, and ORR as indicators were relatively robust, while the results obtained with CBR as indicators lacked robustness. CONCLUSIONS ADC drugs have significant effects on breast cancer, but will increase the risk of anemia and elevated AST.
5.Mitochondrial protein IF1 is a potential regulator of glucagon-like peptide (GLP-1) secretion function of the mouse intestine.
Ying WANG ; Jiaojiao ZHANG ; Xinyu CAO ; Yaya GUAN ; Shuang SHEN ; Genshen ZHONG ; Xiwen XIONG ; Yanhong XU ; Xiaoying ZHANG ; Hui WANG ; Jianping YE
Acta Pharmaceutica Sinica B 2021;11(6):1568-1577
IF1 (ATPIF1) is a nuclear DNA-encoded mitochondrial protein whose activity is inhibition of the F
6.Validation of endotoxin test for high concentration vitamin B6 injection
Juan SHEN ; Jiayue LU ; Xiaoru LUO ; Xiwen WANG
Journal of Pharmaceutical Practice 2020;38(1):67-70
Objective To establish a bacterial endotoxin test method for high concentration vitamin B6 injection. Method The test was taken according to the bacterial endotoxin test in Chinese pharmacopoeia 2015 edition. Result By diluting the sample concentration to 1.04 mg/ml with the buffer of pH6.5-7.5, and using λ=0.06 EU/ml of TAL reagent, the interference could be effectively avoided. Conclusion The method was useful, which could be used to test the bacterial endotoxin in high concentration vitamin B6 injection. The bacterial endotoxin limit was defined as 0.06 EU/mg.
7.Effect of Pyrroloquinoline Quinone on Aging of Rat Hippocampal Neurons in Vitro
Xiwen TONG ; Yanmei HAN ; Yonghui DENG ; Hui SHEN ; Shunhua XIONG
Chinese Journal of Rehabilitation Theory and Practice 2008;14(9):804-805
Objective To investigate the effect of pyrroloquinoline quinone(PQQ) on the aging of rat hippocampal neurons induced by D-galactose(D-gal).Methods Hippocampal neurons were cultured in vitro.The aging of the hippocampal neurons was induced by high dose D-gal,PQQ protection were used 30 min before D-gal.The metamorphosis of hippocampal neurons was observed under the microscope.The contents of free radical was measured.The incidence of apoptosis of hippocampus cells was tested with the flow cytometry.The expression of Bax was detected with immunohistochemical staining.Results After the cells cultured in vitro exposed to D-gal,the content of free radical and the expression of Bax of the hippocampal neurons increased.After pretreatment of the cultured neurons with PQQ,the contents of free radical and the expression of Bax decreased,the survival of hippocampal neurons increased.Conclusion PQQ may slow the aging progress of hippocamal neurons induced by D-gal.


Result Analysis
Print
Save
E-mail